Cargando…

High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients

BACKGROUND: To report the clinical outcome of high dose rate brachytherapy as sole treatment for clinically localised prostate cancer. METHODS: Between March 2004 and January 2008, a total of 351 consecutive patients with clinically localised prostate cancer were treated with transrectal ultrasound...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tselis, Nikolaos, Tunn, Ulf W, Chatzikonstantinou, Georgios, Milickovic, Natasa, Baltas, Dimos, Ratka, Markus, Zamboglou, Nikolaos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671130/ https://www.ncbi.nlm.nih.gov/pubmed/23656899 http://dx.doi.org/10.1186/1748-717X-8-115

Ejemplares similares

High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
por: Behmueller, Manuel, et al.
Publicado: (2021)

Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme
por: Chatzikonstantinou, Georgios, et al.
Publicado: (2019)

Radiobiological evaluation of the influence of dwell time modulation restriction in HIPO optimized HDR prostate brachytherapy implants
por: Mavroidis, Panayiotis, et al.
Publicado: (2010)

Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme
por: Archavlis, Eleftherios, et al.
Publicado: (2013)

Treating the Chameleon: Radiotherapy in the management of Renal Cell Cancer
por: Tselis, Nikolaos, et al.
Publicado: (2019)

Interstitial multicatheter HDR-brachytherapy as accelerated partial breast irradiation after second breast-conserving surgery for locally recurrent breast cancer
por: Chatzikonstantinou, Georgios, et al.
Publicado: (2021)

Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach
por: Fleischmann, Maximilian, et al.
Publicado: (2022)

Effects of iodinated contrast agent on HU-based dose calculation and dose delivered in iridium-192 high-dose-rate brachytherapy
por: Scherf, Christian, et al.
Publicado: (2022)

Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of view
por: Scherf, Christian, et al.
Publicado: (2021)

Radioimmunotherapy: future prospects from the perspective of brachytherapy
por: Fleischmann, Maximilian, et al.
Publicado: (2021)

Dosimetric Impact of the Positional Imaging Frequency for Hypofractionated Prostate Radiotherapy – A Voxel-by-Voxel Analysis
por: Splinter, Mona, et al.
Publicado: (2020)

Effect of using different U/S probe Standoff materials in image geometry for interventional procedures: the example of prostate
por: Diamantopoulos, Stefanos, et al.
Publicado: (2011)

Comprehensive brachytherapy: physical and clinical aspects
por: Venselaar, Jack L M, et al.
Publicado: (2013)

Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies
por: Zoga, Eleni, et al.
Publicado: (2022)

High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome
por: Strouthos, Iosif, et al.
Publicado: (2021)

Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy
por: Fleischmann, Max, et al.
Publicado: (2019)

Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2016)

Narrative Review of High-Dose-Rate Interstitial Brachytherapy in Primary or Secondary Liver Tumors
por: Karagiannis, Efstratios, et al.
Publicado: (2022)

Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference
por: Spohn, Simon K. B., et al.
Publicado: (2021)

Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
por: Fleischmann, Maximilian, et al.
Publicado: (2021)

New (125)I brachytherapy source IsoSeed I25.S17plus: Monte Carlo dosimetry simulation and comparison to sources of similar design
por: Pantelis, Evaggelos, et al.
Publicado: (2013)

Prostate cancer tumour control probability modelling for external beam radiotherapy based on multi-parametric MRI-GTV definition
por: Sachpazidis, Ilias, et al.
Publicado: (2020)

Memorandum 351
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1983)

A detailed dosimetric comparison between manual and inverse plans in HDR intracavitary/interstitial cervical cancer brachytherapy
por: Trnková, Petra, et al.
Publicado: (2011)

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
por: Ju, Andrew W, et al.
Publicado: (2013)

Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients
por: Longheu, Alessandro, et al.
Publicado: (2020)

Brachytherapy for Prostate Cancer: A Systematic Review
por: Koukourakis, Georgios, et al.
Publicado: (2009)

A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer
por: Portner, R., et al.
Publicado: (2021)

Improved source path localisation in ring applicators and the clinical impact for gynecological brachytherapy
por: Humer, Irene, et al.
Publicado: (2015)

CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases
por: Ilyas, Rimal, et al.
Publicado: (2023)

A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer
por: Yoshida, Ken, et al.
Publicado: (2019)

Health Tract No. 351: Onions
Publicado: (1868)

BiopSee(®) – transperineal stereotactic navigated prostate biopsy
por: Zogal, Pawel, et al.
Publicado: (2011)

Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM()
por: Kirisits, Christian, et al.
Publicado: (2014)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective
por: Yoshioka, Yasuo, et al.
Publicado: (2014)

Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
por: Contreras, Jessika A., et al.
Publicado: (2015)

Dose coverage comparison between “interstitial catheter-only” and “hybrid intracavitary-interstitial brachytherapy” for early stage squamous cell carcinoma of the buccal mucosa
por: Murakami, Naoya, et al.
Publicado: (2018)

Source strength determination in iridium-192 and cobalt-60 brachytherapy: A European survey on the level of agreement between clinical measurements and manufacturer certificates
por: Vijande, Javier, et al.
Publicado: (2021)

Investigating Hydroclimatic Variables Trends on the Natural Lakes of Western Greece Using Earth Observation Data
por: Gourgouletis, Nikolaos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tb33kjhaocos1idf9c7l9e5jku